Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

14:05 EST 23rd January 2019 | BioPortfolio

Showing News Articles 1–25 of 430,000+

Wednesday 23rd January 2019

Topix Appoints Key Leadership Talent

Skincare Leader Investing for Growth Topix Pharmaceuticals, the leading independent provider of premium, custom and branded skincare, today announced the creation of several key new leadership roles. Topix is led by CEO & President Brenda Wu and is backed by New Mountain Capital, a growth-oriented investment firm that currently manages more than $2...

How a no-deal Brexit could impact the medical devices sector

From delays in accessing life-saving medicines to diminished medical research, the impact a no-deal Brexit could have on the medical devices sector is potentially profound. As the likelihood The post How a no-deal Brexit could impact the medical devices sector appeared first on Compelo Medical Devices.

New International Prescription Vouchers Allow Consumers to Purchase Medications in U.S. for Those Overseas

NewsConsumers can purchase medications in the U.S for their loved ones in Latin America, and Hoy Health will home-deliver within 24 hours.

Church Pension Group Releases 2018 Denominational Health Plan Annual Report

The Church Pension Group (CPG), a financial services organization that serves the Episcopal Church, recently released The Episcopal Church Medical Trust (Medical Trust) 2018 Denominational Health Plan (DHP) Annual Report, available in English a

Miller Barondess Files Suit on Behalf of FGPQ LLC against PayQwick, Inc. and Its Executive Officers for Fraud

The lawsuit, filed in Los Angeles County Superior Court, alleges that Defendants PayQwick, Inc. and its executive team, consisting of CEO Keith Marks, President Kenneth Berke and CFO Albert Acevedo, defrauded Plaintiff FGPQ LLC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190123005701/en/ ...

GMP Awarded Significant Medical Equipment and Supplies Contract from VA Federal Supply System

Government Marketing & Procurement, LLC (GMP), a trusted solutions provider for government agencies, announced today the recent award of a VA Federal Supply System Schedule 65IIA (Medical Equipment and Supplies) contract. GMP will provide the VA, DoD and other government health agencies top performing products and solutions to improve clinical and qual...

DIY smear tests: are they the answer to falling cervical screening rates?

Young women delay or fail to attend cervical screening appointments because of embarrassment and a fear of being hurt, a new survey has found.1 The findings add to growing pressure to increase...

Chaplaincy for the 21st century: tackling a complex mosaic of agnosticism and provisional beliefs

Patients deserve spiritual or existential care from someone they trust and feel connected with. In this respect, some patients may prefer a spiritual carer who is not religiously categorised. But...

Vaccination: “fake news” on social media may be harming UK uptake, report warns

The spread of misinformation and “fake news” on social media may be fuelling public concern about potential side effects of vaccination and could restrict uptake, the Royal Society for Public Health...

Vedanta Biosciences Announces Publication in Nature of Seminal Research Revealing A New Mechanism of Human Microbiota-Driven Antitumor Immunity Involving Induction of IFNy+ CD8+ T Cell Accumulation in the Gut and Tumors

Research also identified a rationally-defined consortium of human commensal bacteria (VE800) that robustly induces IFNy+ CD8+ T cells and enhances antitumor immunity Vedanta’s clinical candidate VE800 is expected to enter clinical studies in 2019 in combination with Bristol-Myers Squibb’s checkpoint inhibitor OPDIVO® (nivolumab)

New Water Splitting Catalyst Could Make it Easier to Generate Solar Fuel

NewsWater splitting, the process of harvesting solar energy to generate energy-dense fuels.Contributed Author: 

New tumour test could guide personalised treatment for children with cancer

Scientists at the University of British Columbia and BC Children's Hospital are the first in Canada to use a new test for paediatric tumour analysis that may one day guide personalised treatments for children with cancer. Working with researchers at...

UBS: Teva too cheap to ignore

Analyst Navin Jacob feels that the capital market overestimates the Israeli pharmaceutical company's debt risk.

January is #CervicalHealthMonth! Our goal is to highlight the importance of education and prevention. RT to raise awareness! https://bit.ly/2rn9uMO pic.twitter.com/Nr4Sqyiedu

January is #CervicalHealthMonth! Our goal is to highlight the importance of education and prevention. RT to raise awareness! https://bit.ly/2rn9uMO  pic.twitter.com/Nr4Sqyiedu

AEVIS VICTORIA SA: Rosenklinik, ideally located in the canton of St-Gallen, joins Swiss Medical Network

AEVIS VICTORIA SA / Key word(s): Acquisition 23-Jan-2019 / 17:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. PRESS RELEASE Rosenklinik, ideally located in the canton of St-Gallen, joins Swiss Medical Network Located in the centre of Rapperswill, in the canton of St. Gallen, and easily accessi...

STAT Plus: Trump plan to force drug makers to advertise prices might work, but not if pharma gets its way

“For the law to work, the price disclosure on TV ad has to be in a ‘the price, the whole price, and nothing but the price’ scenario,” study co-author Ge…

In a phase 1/2 clinical trial, #genetherapy with autologous hematopoietic stem cells significantly reduced transfusion requirement in adults and children with transfusion dependent ß-thalassemia: https://go.nature.com/2Uc6E6N pic.twitter.com/EDX14PuRXb

In a phase 1/2 clinical trial, #genetherapy with autologous hematopoietic stem cells significantly reduced transfusion requirement in adults and children with transfusion dependent ß-thalassemia: https://go.nature.com/2Uc6E6N  pic.twitter.com/EDX14PuRXb

Acute Ischemic Stroke Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Acute Ischemic Stroke Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Acute Ischemic Stroke Global Clinical Trials Review, H2, 2018" provides an overview of Acute Ischemic Stroke clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Ischemic Stroke. Report includes an overview of trial numbers and their average enrol...

Including prices on TV ads only works when the price is listed alone http://bit.ly/2FLjTbi  #pharma #Healthcare

Including prices on TV ads only works when the price is listed alone http://bit.ly/2FLjTbi  #pharma #Healthcare

Modulated Imaging Raises $7M in Series B Funding

First close of $10M round to fund commercialization of Clarifi™ and additional clinical studies Modulated Imaging, recognized leader in optical imaging solutions for noninvasive assessment of tissue health, announced today that it has raised $7 million in Series B funding. Led by Pangaea Ventures, the round also features new and returning ...

National Library of Medicine Creating Scientific Director Position

David Raths, Contributing EditorAs part of a reorganization of its intramural research activities, the U.S. National Library of Medicine (NLM) has launched a search for a scientific director, a newly created position.

3D Imaging Sensor and Hardware Subsystem Market to Reach $57.9 Billion Worldwide by 2025, According to Tractica

Mobile, Automotive, Drones, and Consumer Applications Will Lead in 3D Camera and Sensor Adoption With advances in computer vision technology, it has become possible to capture 3D images using many different sensors and, in the process, to extract depth information. According to a new report from Tractica, the low cost and versatility of this computer v...

India Pharma scaling up R&D, clinical research activities

In order to catch the wave of the emerging opportunities in the domestic as well as international markets, the Indian pharma is scaling up research and development (R&D) as well as clinical research activities.

Syngene International net profit up by 6% in Q3 to Rs.87 cr

Syngene International, a Rs.1,400 crore contract research and manufacturing services company belonging to Biocon, has posted consolidated net profit growth of 6.1 per cent during the third quarter

Tab. Glibenclamide 5 Mg

Tab. Glibenclamide 5 Mg


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device tracking service collates press releases, news articles and blogs from over 500 sources.  Continuous news is published on the BioPortfolio site, categorised into core topics and posted to our social media accounts - currently 127,000 followers (January 2019):